Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

At current levels, we believe GILD scores above BMY, buoyed by solid fundamentals, potential approval of lenacapavir for HIV ...

HIV, or Human Immunodeficiency Virus, is a type of virus that weakens the immune system, making one susceptible to a variety of infections. Although there is no cure for HIV, with the right treatment, ...

Early on, human immunodeficiency virus (HIV) typically causes flu ... attacks cells in your immune system known as CD4 cells. If untreated, HIV may progress to acquired immunodeficiency syndrome ...

Health Secretary Robert F. Kennedy Jr.’s purge of tens of thousands of federal workers has halted efforts to collect data on everything from cancer rates in firefighters to mother-to-baby transmission ...

Mar. 19, 2025 — New study demonstrates how high-affinity B cells 'bank' their ... Until now, how the virus manages to ... New Therapy May Effectively Control HIV in Uganda Feb. 19, 2025 ...

A modelling study shows the six-monthly anti-HIV jab, lenacapavir, could end Aids in SA by 2032 — but only if between two and ...

Sexually transmitted infections (STIs) could lead to more than just an awkward chat with your latest fling. Research suggests ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine ...

The mass layoffs of federal workers under Health Secretary Robert F. Kennedy Jr. have impaired data-gathering on critical ...

Humans have come a long way as the most dominant species on Earth, largely due to sophisticated adaptations, ingenuity, and ...